Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts

Influence of Nuclides and Chelators on Imaging Using Affibody Molecules: Comparative Evaluation of Recombinant Affibody Molecules Site-Specifically Labeled with 68Ga and 111In via Maleimido Derivatives of DOTA and NODAGA

(2013) Mohamed Altai et al.   BIOCONJUGATE CHEMISTRY

HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules

(2013) Camilla Hofström et al.   JOURNAL OF MEDICINAL CHEMISTRY

Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging

(2013) Hadis Honarvar et al.   NUCLEAR MEDICINE AND BIOLOGY

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

(2013) Magdalena Malm et al.   PLoS One

Novel Radiolabeled Peptides for Breast and Prostate Tumor PET Imaging: 64Cu/and 68Ga/NOTA-PEG-[d-Tyr6,βAla11,Thi13,Nle14]BBN(6–14)

(2012) Patrick Fournier et al.   BIOCONJUGATE CHEMISTRY

Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of 111In-Labeled Synthetic Anti-HER2 Affibody Molecules

(2012) Anna Perols et al.   BIOCONJUGATE CHEMISTRY

[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

(2012) Anna Orlova et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

(2012) V. Tolmachev et al.   JOURNAL OF NUCLEAR MEDICINE

Designed hydrophilic and charge mutations of the fibronectin domain: towards tailored protein biodistribution

(2012) B. J. Hackel et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors

(2012) Jörgen Carlsson   TUMOR BIOLOGY

68Ga-DOTA-Affibody molecule for in vivo assessment of HER2/neu expression with PET

(2011) Gabriela Kramer-Marek et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts

(2011) Jennie Malmberg et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

(2011) Naoki Niikura et al.   JOURNAL OF CLINICAL ONCOLOGY

Engineered High-Affinity Affibody Molecules Targeting Platelet-Derived Growth Factor Receptor β In Vivo

(2011) M. Lindborg et al.   JOURNAL OF MOLECULAR BIOLOGY

Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with 18F-Labeled Affibody Molecule ZHER2:2395 in a Mouse Model for Ovarian Cancer

(2011) S. Heskamp et al.   JOURNAL OF NUCLEAR MEDICINE

Treatment of HER2-positive breast cancer: current status and future perspectives

(2011) Carlos L. Arteaga et al.   Nature Reviews Clinical Oncology

Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody

(2011) Jennie Malmberg et al.   NUCLEAR MEDICINE AND BIOLOGY

Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA

(2011) Mohamed Altai et al.   NUCLEAR MEDICINE AND BIOLOGY

PET Imaging of Tumor Neovascularization in a Transgenic Mouse Model with a Novel 64Cu-DOTA-Knottin Peptide

(2010) C. H. Nielsen et al.   CANCER RESEARCH

Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size

(2010) C. Zahnd et al.   CANCER RESEARCH

Radionuclide Molecular Imaging Using Affibody Molecules

(2010) Sara Ahlgren et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue

(2010) Vladimir Tolmachev et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications

(2010) J. Löfblom et al.   FEBS LETTERS

Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules

(2010) R. P. Baum et al.   JOURNAL OF NUCLEAR MEDICINE

Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis

(2010) L. Pusztai et al.   ONCOLOGIST

Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry

(2009) V. Tolmachev et al.   JOURNAL OF NUCLEAR MEDICINE

On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

(2009) A. Orlova et al.   JOURNAL OF NUCLEAR MEDICINE

Evaluation of the Radiocobalt-Labeled [MMA-DOTA-Cys61]-ZHER2:2395-Cys Affibody Molecule for Targeting of HER2-Expressing Tumors

(2009) Helena Wållberg et al.   MOLECULAR IMAGING AND BIOLOGY

Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of99mTc-Labeled Anti-HER2 Affibody Molecules

(2008) Thuy A. Tran et al.   BIOCONJUGATE CHEMISTRY

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake

(2008) Torun Ekblad et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression

(2008) Clemens Decristoforo et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING